Supporting the Foundation for the National Institutes of Health and the Reagan-Udall Foundation for the Food and Drug Administration Act
USA117th CongressS-1662| Senate
| Updated: 3/15/2022
Ben Ray Luján
Democratic Senator
New Mexico
Cosponsors (2)
Health, Education, Labor, and Pensions Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Supporting the Foundation for the National Institutes of Health and the Reagan-Udall Foundation for the Food and Drug Administration Act This bill increases the amount of funds each fiscal year that the Food and Drug Administration (FDA) must transfer to the Reagan-Udall Foundation for the FDA and that the National Institutes of Health (NIH) must transfer to the Foundation for the NIH. Specifically, it requires each agency to increase the amount transferred to its respective foundation (1) from a minimum of $500,000 to a minimum of $1,250,000, and (2) from a maximum of $1,250,000 to a maximum of $5,000,000.
Suggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in Senate
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Committee on Health, Education, Labor, and Pensions. Ordered to be reported without amendment favorably.
Committee on Health, Education, Labor, and Pensions. Reported by Senator Murray without amendment. Without written report.
Placed on Senate Legislative Calendar under General Orders. Calendar No. 76.
Passed Senate without amendment by Voice Vote. (consideration: CR S4793; text: CR S4793)
Passed/agreed to in Senate: Passed Senate without amendment by Voice Vote.(consideration: CR S4793; text: CR S4793)
Message on Senate action sent to the House.
Received in the House.
Held at the desk.
Latest Companion Bill Action
HR 117-3743Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 181.
Mr. Pallone moved to suspend the rules and pass the bill.
Considered under suspension of the rules. (consideration: CR H1159-1160)
DEBATE - The House proceeded with forty minutes of debate on S. 1662.
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H1159)
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H1159)
Motion to reconsider laid on the table Agreed to without objection.
Presented to President.
Signed by President.
Became Public Law No: 117-101.
Health
Department of Health and Human ServicesDrug safety, medical device, and laboratory regulationExecutive agency funding and structureFood and Drug Administration (FDA)Medical researchNational Institutes of Health (NIH)Research administration and fundingSocial work, volunteer service, charitable organizations
Supporting the Foundation for the National Institutes of Health and the Reagan-Udall Foundation for the Food and Drug Administration Act
USA117th CongressS-1662| Senate
| Updated: 3/15/2022
Supporting the Foundation for the National Institutes of Health and the Reagan-Udall Foundation for the Food and Drug Administration Act This bill increases the amount of funds each fiscal year that the Food and Drug Administration (FDA) must transfer to the Reagan-Udall Foundation for the FDA and that the National Institutes of Health (NIH) must transfer to the Foundation for the NIH. Specifically, it requires each agency to increase the amount transferred to its respective foundation (1) from a minimum of $500,000 to a minimum of $1,250,000, and (2) from a maximum of $1,250,000 to a maximum of $5,000,000.
Suggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in Senate
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Committee on Health, Education, Labor, and Pensions. Ordered to be reported without amendment favorably.
Committee on Health, Education, Labor, and Pensions. Reported by Senator Murray without amendment. Without written report.
Placed on Senate Legislative Calendar under General Orders. Calendar No. 76.
Passed Senate without amendment by Voice Vote. (consideration: CR S4793; text: CR S4793)
Passed/agreed to in Senate: Passed Senate without amendment by Voice Vote.(consideration: CR S4793; text: CR S4793)
Message on Senate action sent to the House.
Received in the House.
Held at the desk.
Latest Companion Bill Action
HR 117-3743Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 181.
Mr. Pallone moved to suspend the rules and pass the bill.
Considered under suspension of the rules. (consideration: CR H1159-1160)
DEBATE - The House proceeded with forty minutes of debate on S. 1662.
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H1159)
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H1159)
Motion to reconsider laid on the table Agreed to without objection.
Presented to President.
Signed by President.
Became Public Law No: 117-101.
Ben Ray Luján
Democratic Senator
New Mexico
Cosponsors (2)
Health, Education, Labor, and Pensions Committee
Health
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Department of Health and Human ServicesDrug safety, medical device, and laboratory regulationExecutive agency funding and structureFood and Drug Administration (FDA)Medical researchNational Institutes of Health (NIH)Research administration and fundingSocial work, volunteer service, charitable organizations